Medican Enterprises Announces a Joint-Venture In Creating a New Wine to Compliment Our Brand

LAS VEGAS--()--Medican Enterprises, Inc. (OTCBB:MDCN), is pleased to announce that it has signed a joint-venture with El Encanto Vineyards, a recently-acquired, wholly-owned subsidiary of Newealth US, Inc. / Universal Apparel & Textile Company (DKGR:OTC), in creating a newly branded Moscato wine that will complement the cannabis brands that Medican is bringing to market. With the wine industry in California suffering from a severe drought, El Encanto Vineyards, in New Mexico has a strategic advantage due to its abundance of geothermal water necessary for its vineyards and ideal sun and soil to make a perfect wine for our customers. In addition to Michigan, as we mentioned in our last press release, we plan to target the states of Colorado, Alaska and Washington initially for the distribution of our cannabis products and the entire US for our wine products.

Medican CEO, Kenneth Williams commented, “I am very pleased to work with Eugene Turner, CEO of Newealth US /Universal Apparel & Textile Company (DKGR:OTC), and the esteemed Anthony Silveira in creating this brand. There are 20 acres of land in New Mexico that are to be immediately established for growing the grapes for Medican’s wine as part of this joint-venture and 200 acres ultimately available.” In the meantime, Moscato will be available from comparable local Newealth licensed vineyards for distribution in 60 days sporting the Medican brand. Also available is land for our patrons to own their own section of vineyard to “Own the Land and Create the Brand”.

The vision is for Medican to have a branded wine. The initial Moscato vintage label "D420" will focus on capturing a market share of the $1.2 trillion annual "black" hip hop retail market. This strategic move will create a first product in a long line of vintages to come branded under Medican labels.

About Medican Enterprises, Inc.

Medican Enterprises is a bio-pharmaceutical company focused on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its subsidiaries, Medican is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of medical and recreational marijuana, both in the United States and Canada. For more information visit: http://medican.enterprises

Cautionary Note Regarding Forward-Looking Statements

This press release and statements of representatives of Medican Enterprises, Inc. (the “Company”) related thereto includes forward-looking statements within the meaning of the U.S. federal securities laws. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to significant risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control), which could cause actual results to differ from the forward looking statements. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, projections, expectations and intentions and other statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential" or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management but are subject to significant risks and uncertainties, including those detailed in the Company's filings with the Securities and Exchange Commission. Actual results (including, without limitation, the results of the Company’s efforts to acquire and integrate Future Harvest as described herein) may differ from those set forth in the forward-looking statements. Except as required by applicable law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contacts

Medican Enterprises Inc.
Ken Williams, CEO
+1-800-416-8802
investors@medican.enterprises

Contacts

Medican Enterprises Inc.
Ken Williams, CEO
+1-800-416-8802
investors@medican.enterprises